Trials / Active Not Recruiting
Active Not RecruitingNCT05300724
An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration
A Multicenter, Prospective, Observational Study of the Progression of Intermediate Age-Related Macular Degeneration
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (actual)
- Sponsor
- Genentech, Inc. · Industry
- Sex
- All
- Age
- 50 Years – 94 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter prospective study in participants with intermediate age-related macular degeneration (iAMD). One primary objective of this study is to assess iAMD disease progression, by the timeline and rates of conversion for high-risk iAMD at baseline to more advanced atrophic AMD stages. The other primary objective of this observational study is to assess the feasibility of measuring the rate of photoreceptor loss as a potential clinical endpoint. The study will consist of an observation period of approximately 3 years (\~144 weeks) for participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No intervention will be administered in this study. |
Timeline
- Start date
- 2022-05-27
- Primary completion
- 2027-06-30
- Completion
- 2027-06-30
- First posted
- 2022-03-29
- Last updated
- 2026-03-23
Locations
74 sites across 7 countries: United States, Australia, France, Germany, Israel, Italy, Puerto Rico
Source: ClinicalTrials.gov record NCT05300724. Inclusion in this directory is not an endorsement.